Crossmark

Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure

Crossref DOI link: https://doi.org/10.1007/s00277-018-3443-1

Published Online: 2018-07-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hosokawa, Kohei

Sugimori, Chiharu

Ishiyama, Ken

Takamatsu, Hiroyuki

Noji, Hideyoshi

Shichishima, Tsutomu

Obara, Naoshi

Chiba, Shigeru

Ninomiya, Haruhiko

Shirasugi, Yukari

Nakamura, Yoshihiko

Ando, Kiyoshi

Ueda, Yasutaka

Yonemura, Yuji

Kawaguchi, Tatsuya

Nishimura, Jun-ichi

Kanakura, Yuzuru

Nakao, Shinji
License Information

Text and Data Mining valid from 2018-07-24
More Information

Article History

Received: 19 November 2017

Accepted: 13 July 2018

First Online: 24 July 2018

Compliance with ethical standards

: All human subjects were collected after obtaining written informed consent for their participation in accordance with the Declaration of Helsinki through clinical protocols approved by the Institutional Review Board.

: Dr. Ninomiya, Dr. Shichishima, Dr. Yonemura, Dr. Kawaguchi, and Dr. Nakao report personal fees from Alexion Pharma G.K., outside the submitted work; Dr. Ninomiya, Dr. Chiba, Dr. Ueda, Dr. Yonemura, and Dr. Nakao report grants from Alexion Pharma G.K., outside the submitted work; Dr. Kanakura and Dr. Nishimura report grant and personal fees from Alexion Pharma G.K. during the conduct of the study; Dr. Shirasugi report honoraria from Novartis; Dr. Hosokawa, Dr. Sugimori, Dr. Ishiyama, Dr. Takamatsu, Dr. Noji, Dr. Obara, Dr. Nakamura, and Dr. Ando have nothing to declare.